Latin America Radiation Oncology Market Size & Outlook
The radiation oncology market in Latin America is expected to reach a projected revenue of US$ 1,682.4 million by 2033. A compound annual growth rate of 12% is expected of Latin America radiation oncology market from 2026 to 2033.
Siemens Healthineers AG ADR, Elekta AB ADR, BD, Accuray Inc, IBA RadioPharma Solutions, IsoRay, MeVis Medical Solutions AG, Nordion, Ntp Radioisotopes, Curium Pharma, ViewRay
Other key industry trends
In terms of revenue, Latin America region accounted for 4.9% of the global radiation oncology market in 2025.
Globally, North America is projected to lead the regional market in terms of revenue in 2033.
Asia Pacific is the fastest growing regional market and is projected to reach USD 7,241.2 million by 2033.
Rising incidence of cancer and rise in mortality rates due to the disease are expected to fuel the market growth. According to the Pan American Health Organization, cervical cancer is the most common cause of deaths in Latin America and Caribbean region.
It is estimated that more than 56,000 women are diagnosed with cervical cancer, and more than 28,000 die from this disease in this region every year. The mortality rate is three times higher in this region in comparison with North America.
Hence, IAEA Division of Human Health is supporting early diagnosis and treatment of cancer using diagnostic imaging and radiation therapy (EBRT & Brachytherapy) in this region. In addition, presence of key market players such as ElektaAB and Varian Medical Systems.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Radiation Oncology Market Outlook will help companies and investors design strategic landscapes.
External Beam Radiation Therapy (Ebrt) was the largest segment with a revenue share of 86.52% in 2025.
Horizon Databook has segmented the Latin America radiation oncology market based on external beam radiation therapy (ebrt), internal beam radiation therapy, systemic targeted radiation therapy covering the revenue growth of each sub-segment from 2021 to 2033.
Rising incidence of cancer and rise in mortality rates due to the disease are expected to fuel the market growth. According to the Pan American Health Organization, cervical cancer is the most common cause of deaths in Latin America and Caribbean region.
It is estimated that more than 56,000 women are diagnosed with cervical cancer, and more than 28,000 die from this disease in this region every year. The mortality rate is three times higher in this region in comparison with North America.
Hence, IAEA Division of Human Health is supporting early diagnosis and treatment of cancer using diagnostic imaging and radiation therapy (EBRT & Brachytherapy) in this region. In addition, presence of key market players such as ElektaAB and Varian Medical Systems.
Latin America Radiation Oncology Market Treatment Type Outlook (Revenue, USD Million , 2021-2033)
External Beam Radiation Therapy (EBRT)
Internal Beam Radiation Therapy
Systemic Targeted Radiation Therapy
Latin America Radiation Oncology Market Technology Outlook (Revenue, USD Million , 2021-2033)
Image-Guided Radiotherapy (IGRT)
Intensity-Modulated Radiotherapy (IMRT)
Volumetric Modulated Arc Therapy (VMAT)
3D Conformal Radiation Therapy (3D-CRT)
Stereotactic Radiotherapy (SRS / SBRT)
Proton Beam Delivery Technology
Heavy-Ion Delivery Technology
Adaptive Radiotherapy
Upright Beam Delivery Technology
Latin America Radiation Oncology Market Application Outlook (Revenue, USD Million , 2021-2033)
External Beam Radiation Therapy (EBRT)
Internal Beam Radiation Therapy
Radioligand Therapy Applications
Latin America Radiation Oncology Market Target Customer Outlook (Revenue, USD Million , 2021-2033)
Academic & Research Cancer Centers
Government & Public Tertiary Hospitals
Private Oncology Chains
Specialty Proton / Particle Therapy Centers
Nuclear Medicine & Theranostics Centers
Reasons to subscribe to Radiation Oncology Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Radiation Oncology Market Outlook databook
Our clientele includes a mix of Radiation Oncology Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America Radiation Oncology Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into Latin America Radiation Oncology Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Latin America Radiation Oncology Market, 2021-2033 (US$M)